Johnson & Johnson (JNJ) Stock Issuance Proceeds — Quarterly & Annual

Screener

Stock Issuance Proceeds at other companies

AbbottABT

$3M-91.4%

Merck & Co.MRK

$43M+258%

The Cooper Companies, Inc.COO

$3.9M+77.3%

Merit Medical SystemsMMSI

$2.78M-78.9%

Intuitive SurgicalISRG

$76.6M+23.7%

United TherapeuticsUTHR

$126.3M+598%

Other financials

Income statement

Revenue$25.3B+6.6%

Gross profit$17.3B+7.1%

Operating income$7.1B+7.4%

Net income$5.5B-0.1%

EPS (diluted)$2.27-0.9%

Balance sheet

Cash & equivalents$20.4B+9.9%

Total debt$49.0B-3.4%

Total equity$85.0B+8.3%

Total assets$201.06B+4.0%

Cash flow

Operating cash flow$8.6B+122%

CapEx$1.3B+26.7%

Free cash flow$7.3B+157%

Valuation

Market cap$620.77B+51.1%

Enterprise value$649.38B+46.6%

P/E29.5×+11.4×

P/S6.3×+1.8×

Profitability

Gross margin67.9%0.0pp

Operating margin26.5%+2.8pp

Net margin21.5%-3.5pp

FCF margin22.7%+2.2pp

Returns & leverage

Return on equity25.7%-4.5pp

Debt / equity0.6×-0.1×

Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The source filing: Johnson & Johnson’s 10-K, filed February 23, 2012. Open the filing →

Filed: Feb 23, 2012
Fiscal year: FY2011
Accession: 0001193125-12-075565

FAQ

What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.